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Background: Different bacteria in stool have markedly varied growth and survival when stored at ambient temperature.
It is paramount to develop optimal biostabilization of stool samples during collection and assess long-term storage for
clinical specimens and epidemiological microbiome studies. We evaluated the effect of collection media and delayed
freezing up to 7 days on microbial composition. Ten participants collected triplicate stool samples each into no media
as well as RNAlater® with and without kanamycin or ciprofloxacin. For each set of conditions, triplicate samples were
frozen on dry ice immediately (time = 0) or frozen at −80 °C after 3-days and 7-days incubation at 25 °C. Microbiota
metrics were estimated from Illumina MiSeq sequences of 16S rRNA gene fragments (V3–V4 region). Intraclass
correlation coefficients (ICC) across triplicates, collection media, and incubation time were estimated for taxonomy and
alpha and beta diversity metrics.
Results: RNAlater® alone yielded the highest ICCs for diversity metrics at time = 0 [ICC median 0.935 (range 0.89–0.97)],
but ICCs varied greatly (range 0.44–1.0) for taxa with relative abundances <1 %. The 3- and 7-day freezing delays were
generally associated with stable beta diversity for all three media conditions. Freezing delay caused increased variance
for Shannon index (median ICC 0.77) and especially for observed species abundance (median ICC 0.47). Variance in
observed species abundance and in phylogenetic distance whole tree was similarly increased with a 7-day delay.
Antibiotics did not mitigate variance. No media had inferior ICCs at time 0 and differed markedly from any media in
microbiome composition (e.g., P = 0.01 for relative abundance of Bacteroidetes).
Conclusion: Bacterial community composition was stable for 7 days at room temperature in RNAlater® alone. RNAlater®
provides some stability for beta diversity analyses, but analyses of rare taxa will be inaccurate if specimens are not
frozen immediately. RNAlater® could be used as collection media with minimal change in the microbiota composition.Background
Relationships between the gut bacteria and health are
not new, but an emerging concept is that altered func-
tions of the bacterial community contribute to disease
development collectively, rather than through the action of
specific pathogenic members. Next generation sequencing
approaches have provided powerful tools to study associa-
tions of the human microbiome with disease. Interesting
associations of microbiota and disease have been reported* Correspondence: floresr2@mail.nih.gov
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creativecommons.org/publicdomain/zero/1.0/[1–3], but their etiologic significance has not been assessed
in well-powered case–control or prospective epidemio-
logical studies. To move the field of human microbiome
research forward both for clinical purposes and in epi-
demiological research, validated methods are needed for
collecting specimens that represent, as closely as possible,
the true in vivo parameters and to understand any
technical variation that can be introduced. For large
population-based microbiome studies, specimen collec-
tion methods must be acceptable to participants and, most
importantly, tolerant of suboptimal field conditions. If
optimal collection and storage conditions (i.e. immediate
freezing and storage at −80 °C) are not possible, sys-
tematic bias can be introduced in preprocessing steps [4].
Therefore, it is imperative to minimize possible artifactsicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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be easily implementable for both clinical uses and for large
field-based epidemiologic studies.
Analysis of microbial diversity in human specimens
poses important challenges, especially and particularly
for field epidemiological studies where a cold chain
cannot always be maintained or assured from sample
collection to freezer storage. Specimens collected in the
field may often spend various amounts of time at room
temperature, followed by shipment on frozen gel packs
(4 °C) or dry ice to a central laboratory for processing or
storage. Fecal samples may not be representative of the
whole gastrointestinal (GI) tract or specific loci within
the GI, but a recent study showed that it is the relative
abundance of taxa that differs rather than the lack of
representation in stool as compared to mucosa-associated
microbiota [5]. For screening purposes stool could be
used to detect and quantify putative bacterial species
as biomarkers of microbiota associated carcinogenesis
as in the case of colorectal cancer [6–8].
Recent efforts to systematically evaluate and standardize
post collection analysis of the microbiota will undoubtedly
homogenize protocols and facilitate comparison among
studies (www.mbqc.org). However, few studies have evalu-
ated the pre-analytical steps focusing on stability of the
microbiome in stool samples collected under field
conditions. Very few reports have focused on the impact
of preservation medium, time and temperature on the
microbial community structure and other microbiota
metrics of alpha and beta diversity [9]. RNAlater® has
been suggested as the preservative of choice to con-
serve the stability of nucleic acids, both DNA and
RNA, in tissue and other biospecimens [10–14]. However,
the sufficiency of RNAlater® alone to prevent differential
growth of bacteria during typical delays in field stud-
ies is unknown. Addition of antibiotics that preventsFig. 1 Comparison of major phyla in fecal samples stored in different medeither RNA transcription or protein translation may
improve biostabilization. Previous reports have yielded
inconsistent results for the effects of room temperature
storage on DNA and RNA stability for microbial analysis
[15–19] As the microbiome field is advancing from
descriptive to longitudinal or prospective studies, it is
important to systematically evaluate the collection
methods and the media used to biopreserve the micro-
biome integrity in stool. In this report, we describe a
systematic evaluation of the effects of preservation
media and storage conditions on the composition of
the fecal microbiota as analyzed by 16S rRNA gene
profiling (V3-V4 region) using Illumina MiSeq sequen-
cing. The objective of this study was to evaluate RNAlater
as a biopreservative for large, population-based studies;
a biopreservative for human microbiome analyses of
stool samples that remain unfrozen for as long as
seven days.
Results and discussion
Reproducibility of microbiota metrics with no collection
media and RNAlater-based collection media
We first compared the microbial composition of stool
replicates collected without collection media to those
collected with different media at time zero. As shown in
Fig. 1, compared to specimens collected in RNAlater®-
based media, specimens collected without media had
significantly different microbial composition, with a
marked reduction in relative abundance of Bacteroi-
detes, a smaller reduction of Proteobacteria, and a com-
pensatory increase in Actinobacteria and Firmicutes.
Compared to media conditions, particularly RNAlater®
alone, the no media condition also had lower ICCs for
reproducibility of relative abundance for Bacteroidetes
(ICC 0.71), alpha diversity estimates (mean of four esti-
mates, ICC 0.865 versus 0.935 for RNAlater® alone), andia at baseline
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differences in relative abundance and reproducibility,
we restricted the rest of our analysis to conditions
using media.
Reproducibility of microbiota metrics with different
collection media at time zero
We first sought to identify differences at time zero
among the three media (RNAlater® alone, RNAlater®
with kanamycin, or with ciprofloxacin) by calculating
ICCs for 14 microbiota metrics across triplicate samples
from the 10 subjects. These metrics included relative abun-
dances of the major phyla (Proteobacteria, Bacteroidetes,
Firmicutes, Actinobacteria), four alpha-diversity metrics
(Shannon, Chao-1, PD_WT, richness), and beta diversity
represented by PCoA scores (Table 1). For all 14 micro-
biome measurements, ICCs were significantly larger than 0
(P≤1.0×10−3). As shown in Table 1, RNAlater® alone yielded
the highest ICCs in all but one of the 14 metrics. However,
with only 10 subjects, none of the pairwise comparisons
was statistically significant. Mean values of the PCoA
scores closely resembled beta diversity estimates based
on weighted UniFrac (0.92 for RNAlater alone) and
unweighted UniFrac (0.76 for RNAlater alone).
We also investigated whether ICCs differed across
taxa by their relative abundances (excluding taxa with
relative abundance <0.1 %). We restricted this analysis
to the RNAlater® alone condition, because it delivered
the highest ICCs. ICCs were high (interquartile range
0.92-0.93) for taxa with relative abundances >8 % and
varied ICCs (interquartile range 0.82-0.96) for taxa
with intermediate relative abundances (1-8 %). A lin-
ear regression model of the mean relative abundance (log
scale) and the ICC of relative abundance showed that taxa
with relative abundances <1 % were highly significantly
correlated with varied ICCs (interquartile range 0.73-0.96)
(Fig. 2, Ptrend=0.0007).
Stability of microbiota metrics with delayed freezing
For each media condition and all 14 microbiota metrics,
we compared immediate freezing (time=0) to incubation
for 3 days (time=3) or 7 days (time=7) at room
temperature prior to freezing. Across triplicates and sub-
jects, we calculated ICCs for time=3 vs 0, and for time=7
vs 0 with each media (Table 2).
For time=3 vs 0, taxonomy ICCs (relative abun-
dances by phylum) were higher with RNAlater® with
kanamycin, especially for relatively rare Proteobac-
teria taxa (ICCkanamycin 0.77, vs ICCRNAlater®0.60 and
ICCciprofloxacin 0.54, Table 2). For Shannon index estimate
of alpha diversity, ICC was 0.76-0.77 for all three media.
For the other three alpha diversity estimates, ICCs
were very low, especially ICCkanamycin (0.03-0.47) and
ICCciprofloxacin (0.12-0.56). For unweighted beta diversity,the first principle coordinate had high ICCs (0.88-0.91)
with all three media. For weighted beta diversity, the first
three principal coordinates had high ICCs with all
three media (ICCRNAlater®0.80-0.93; ICCkanamycin 0.83-0.95;
ICCciprofloxacin 0.82-0.97, Table 2).
For time=7 vs 0, ICCs with the three media generally
followed the same pattern as for time=3 vs 0 (Table 2).
For example, taxonomy ICCs (relative abundances by
phylum) were higher with RNAlater® with kanamycin
(e.g., Proteobacteria taxa ICCkanamycin 0.88, vs ICCRNAlater®
0.64 and ICCciprofloxacin 0.62). Other than Shannon
index, alpha-diversity ICCs were much higher with
RNAlater® alone (0.76-0.85) than RNAlater® with kanamycin
(0.44-0.62) or ciprofloxacin (0.34-0.64). Except for a few
principal coordinates, both unweighted and weighted beta
diversity ICCs for time=7 vs 0 were high with all three
media. Mean values of the PCoA scores closely resembled
beta diversity estimates based on weighted UniFrac (0.92
for RNAlater alone) and unweighted UniFrac (0.76 for
RNAlater alone). The strong clustering of weighted beta di-
versity for each of the 10 subjects, incorporating differences
over time and all three media, is illustrated in Fig. 3.
The importance of the human gastrointestinal (GI)
microbiota in health and its possible association with
disease is becoming more evident [20–23]. However,
there is high heterogeneity in specimen collection
methods in the literature and no consensus on methods
to optimally stabilize specimens for microbial composition
analysis. Our study found that human fecal specimens
collected in RNAlater® yield highly reproducible micro-
biome composition (beta diversity) estimates, even if they
were held up to 7 days at room temperature (25 °C)
prior to freezing. Despite this, detection and relative
abundances of rare taxa were altered by delayed freezing,
irrespective of media, which highlights the potential for
bias if specimens are not handled optimally.
To enhance stabilization of the microbiota ex vivo, we
conducted preliminary experiments (not presented) of
RNAlater® without and with individual and combined
antibiotics. Of all the conditions tested, two antibiotics,
kanamycin (through inhibition of protein synthesis) and
ciprofloxacin (through inhibition of DNA replication)
showed promising results when used at bactericidal
concentration (data not shown). The current study built
on these findings by supplementing RNAlater® with a
bactericidal dose (300 μg/ml) of more than 10-fold the
minimal inhibitory concentration of these two antibiotics,
which we compared to RNAlater® alone. We found that
adding antibiotics to RNAlater® did not yield more stable
microbiota metrics in feces left at room temperature for 3
or 7 days. In fact, RNAlater® alone had the highest ICC
values for all major phyla for day 3 and was consistent
over time (day 7). Irrespective of delayed freezing, the high
reproducibility of independent replicates observed for
Table 1 Technical reproducibility, estimated as intraclass correlation (ICC) coefficient and UniFrac distance-based R2, under different conditions and time points
Relativea
abundance





















Actinobacteria 2.1 % 0.98 0.96 0.97 0.92 0.96 0.98 0.89 0.95 0.96 0.99
Bacteroidetes 14.6 % 0.71 0.93 0.84 0.91 0.93 0.88 0.85 0.94 0.97 0.86
Firmicutes 75.1 % 0.97 0.93 0.82 0.89 0.94 0.89 0.84 0.95 0.97 0.87
Proteobacteria 0.6 % 0.95 0.94 0.83 0.32 0.98 0.83 0.90 0.94 0.90 0.88
PD_WT 0.87 0.95 0.87 0.82 0.75 0.47 0.69 0.48 0.72 0.40
Chao1 0.81 0.91 0.74 0.72 0.66 0.25 0.55 0.30 0.59 0.17
Observed_species 0.83 0.92 0.82 0.74 0.74 0.31 0.65 0.46 0.65 0.16
Shannon 0.95 0.96 0.92 0.80 0.89 0.70 0.87 0.76 0.83 0.52
Unweighted.PCoA1 0.96 0.97 0.94 0.95 0.92 0.81 0.93 0.91 0.94 0.83
Unweighted.PCoA2 0.80 0.96 0.87 0.75 0.87 0.61 0.86 0.75 0.84 0.38
Unweighted.PCoA3 0.82 0.89 0.89 0.86 0.89 0.76 0.66 0.86 0.93 0.77
Weighted.PCoA1 0.74 0.95 0.83 0.94 0.92 0.92 0.87 0.90 0.97 0.88
Weighted.PCoA2 0.97 0.97 0.96 0.97 0.96 0.96 0.94 0.97 0.97 0.98
Weighted.PCoA3 0.90 0.91 0.88 0.90 0.91 0.76 0.87 0.95 0.95 0.96
Unweighted UniFrac 0.70 0.75 0.76 0.67 0.79 0.64 0.72 0.70 0.74 0.66
Weighted UniFrac 0.91 0.97 0.92 0.80 0.97 0.89 0.97 0.93 0.91 0.81











Fig. 2 The relative abundance of more common taxon tend to be more reproducible under condition RNAlater at time 0. The figure is based on
taxa with median relative abundance greater than 0.1 % across all samples. Each diamond represents a taxon. The line was fitted by linear regression
using all data points
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plots) suggests that relatively few replicates are needed
with RNAlater® alone as the collection media. This finding
has major implications with regard to large epidemiologic
studies since the cost of collecting and storing multiple
aliquots could be substantially reduced.
Surprisingly, we observed statistically significant dif-
ferences in the microbial composition of the same









p__Actinobacteria 2.10 % 0.96 0.98
p__Bacteroidetes 14.60 % 0.76 0.82
p__Firmicutes 75.10 % 0.73 0.81











Unweighted UniFrac 0.70 0.71
Weighted UniFrac 0.78 0.86
aMedian of the relative abundance across all subjectscollection media compared to no media. All samples
underwent the same extraction method, but our results
indicate a major reduction in relative abundances of
Bacteroides in stool samples collected without collection
media. The no media condition also had inferior ICCs,
which was severe for reproducibility of relative abundance
for Bacteroidetes (ICC 0.71), and also notable for alpha
diversity estimates and some beta diversity estimates
(PCoA scores). It is possible that the thawing process ofand UniFrac distance-based R2, between two time points









0.97 0.98 0.92 0.95
0.81 0.70 0.79 0.69
0.77 0.68 0.77 0.69
0.54 0.64 0.88 0.62
0.56 0.85 0.62 0.64
0.12 0.76 0.44 0.34
0.36 0.78 0.53 0.41
0.76 0.88 0.80 0.69
0.91 0.97 0.91 0.92
0.58 0.88 0.78 0.64
0.64 0.94 0.93 0.80
0.86 0.61 0.80 0.79
0.97 0.96 0.96 0.97
0.82 0.90 0.86 0.87
0.70 0.76 0.76 0.71
0.87 0.75 0.86 0.80
Fig. 3 Principal coordinate analysis of fecal microbiota to evaluate structure reproducibility under different sampling and storage conditions.
Samples from each of the ten subjects are presented with a different color. a Time 0, weighted beta diversity with all media conditions. b Time 0,
unweighted beta diversity at time 0 with all media conditions. c Weighted beta diversity across all media conditions and three time points.
Variation explained was 54.1, 11.6, and 5.7 % for PCoA1, 2, and 3, respectively. d Unweighted beta diversity across all media conditions and three
time points. Variation explained was 14.3, 11.1, and 7.6 % for PCoA1, 2, and 3, respectively
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of members of the phylum Bacteroides. Perhaps such stool
samples stored without collection media needs a special
digestion step after thawing, or requires the immediate
inhibition of potential nucleases that are liberated during
thawing.
Other studies have determined the effect of storage
parameters with stool samples used for microbial
genomic analysis. However, these studies focused on
measuring the quality and quantity of extracted DNA
[24], the effect of room temperature on stool with no
preservation media [25], the robustness of pyrosequencingusing stool samples stored in different conditions and
DNA extraction methods [15], or the effect of temperature
incubation (including freezing) on measures of bacterial
communities in sputum [26]. Lauber et al. reported on the
stability of stool biospecimens for microbiome analysis
using 16SrRNA gene sequencing. In that study, the stool
samples were left at room temperature without storage
media for up to two weeks and found the condition
satisfactory for microbial community analysis even after
this prolonged period [9]. However, because no storage
media were tested in that study, it is not possible to
evaluate if the differences we observed were stable over
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time without storage media, our results also show stability
of microbial community composition for up to 7 days in
RNAlater®. Different mechanisms may contribute to
stability. In Lauber et al., the stool was aliquoted using
cotton swabs with no preservation media and only DNA
was analyzed. The cotton swab may have acted as a desic-
cant for the stool, thus preventing further bacterial growth
during the incubation period. In our study, the RNAlater®
solution, being a liquid media, may diffuse more easily to
the core of the specimen given proper mixing, and is
believed to act as both DNA and RNA stabilizer and
inactivate nucleases when specimens are thawed before
extraction. In addition, RNAlater® is design to enable
measures of RNA transcripts and thus increase its utility
for future epidemiologic studies.
Of interest, a recent report by Cardona et al. suggests
that DNA and RNA from stool samples may degrade at
room temperature even if collected in RNAlater® affecting
the composition of the microbiota for meta-genomic and
-transcriptomic analyses [17]. It is unclear, however, if the
observed degradation of RNA in samples collected with
RNAlater® also corresponds to changes in DNA integrity
and microbial classification since stool samples collected
with RNAlater® were not used for microbial taxonomic
analysis. Our results showed that RNAlater® alone
provides sufficient stability for taxonomic analyses of
bacterial DNA from stool specimens even if left at room
temperature for up to 7 days.
The major limitations of our study are its small size,
with only 10 participants, and exclusive focus on how
delayed freezing and selected media affect the fecal
microbiome. Nonetheless, these issues are critically
important for large epidemiologic field studies. These
were rigorously evaluated with state-of-the-art micro-
biome laboratory and analysis methods. Without question,
more research is needed on other factors that can affect
statistical power and bias, including handling, storing, and
thawing of specimens, microbial cell lysis, nucleic acid
extraction, robustness of sequencing platforms, and
classification and quantification of microbial taxa. The
inclusion of mock communities that are site-specific
would be necessary in future studies of the microbiome,
especially those using clinical specimens, to validate the
methodology in the analysis of microbial communities. As
reported in a recent study by Hang and colleagues, such
mock communities have been developed and evaluated
for thermal stability with the aim to be used as reference
for microbiome studies [27].
Conclusions
The technological advancements in sequencing over the
last 20 years have revolutionized our conceptual frame-
work of microbiota and host interactions. Assessment ofbacterial composition and specific bacterial functions
can be used as a powerful tool to understand their
role in health and disease risk. As a step to help
move the microbiome field to epidemiological studies,
herein we evaluated parameters of microbiome stability
and effects of delayed freezing and collection media on
bacterial community structure based on 16S rRNA
gene sequences. Our data suggest that RNAlater® alone
effectively preserves the composition of the fecal microbial
community for up to 7 days at room temperature,
implying that it could be used for population-based
studies in field settings. The high ICC observed suggests
that fewer replicates can be collected thus saving costs
and storage space. Independent validation is needed, as is
expansion to understand extreme environments and
possible artifactual effects on microbial gene expression.
Methods
Study participants
Ten healthy volunteers (8 male and 2 female) were aged
between 34–61 [mean 44.2]. Five participants had taken
an antibiotic or other medication within one year. Four
participants were taking probiotics at the time of the
study. Following face-to-face instructions and signed
informed consent, participants were provided written
and illustrated instructions and a toilet-attached
pouch (Protocult, Rochester, MN), from which they
collected 30 samples of an early or mid-morning
stool. After specimen collection, they completed a
brief self-administered questionnaire on demographics,
broad dietary categories, ease-of-use of the devices,
and factors potentially related to the gut microbiota.
The study was reviewed and approved by the National
Cancer Institute Special Studies Institutional Review Board
(protocol 10CN107).
Stool specimen collection
Participants were recruited to assess the stability and re-
producibility of microbial measures in self-collected fecal
specimens following a protocol as previously described
[28]. Participants used Sarstedt (Nümbrecht, Germany)
fecal collection devices containing solutions as described
below to collect 30 separate samples from various parts
of a single stool. The fecal vials were either frozen on
dry ice immediately or were incubated at 25 °C (equiva-
lent of room temperature) for the times described below,
following which they were all stored at −80 °C until used
for DNA extraction.
Design, conduct and analysis of the effects of room
temperature and storage media on detection and
classification of bacterial taxa in stool specimens
A summary of the experimental conditions are shown in
Table 3. Briefly, each of the ten participants collected 30
Table 3 Collection media type and room temperature
incubation times evaluated in the study
Media tested Incubation
time 0
Incubation time 1 Incubation time 2
(72 h at 25 °C) (168 h at 25 °C)
No media 3 Aliquots – –
RNAlater® 3 Aliquots 3 Aliquots 3 Aliquots
RNAlater® + Kana 3 Aliquots 3 Aliquots 3 Aliquots
RNAlater® + Ciprob 3 Aliquots 3 Aliquots 3 Aliquots
Study participants (n = 10) sampled aliquots (n = 30) from a single stool which
they stored under different conditions. Subsamples were collected either
without collection media or three different RNAlater-based media and frozen
immediately after collection (time 0) or stored by two time periods (72 and
168 h) at 25 °C before freezing on dry ice and stored at −80 °C
aRNAlater® supplemented with 300 μg/ml Kanamycin
bRNAlater® supplemented with 300 μg/ml Ciprofloxacin
Flores et al. Microbiome  (2015) 3:33 Page 8 of 11aliquots from a single stool, each containing ~0.5-1 g of
feces. Four conditions were used. Three aliquots were
collected in no media; nine aliquots in 5ml of RNAlater®
(Ambion, Austin, TX); nine aliquots in 5ml of RNAlater®
containing 300 μg/ml kanamycin (SIGMA B5264, St
Louis, MO); and nine aliquots in 5ml of RNAlater® con-
taining 300 μg/ml ciprofloxacin (SIGMA 17850). Three
aliquots for each condition were immediately frozen on
dry ice (provided to participants) and the rest of aliquots
were kept at room temperature, then all samples were
brought to the laboratory. After arrival in the lab, the
frozen aliquots were stored at −80 °C and the remaining
aliquots were incubated at room temperature (25 °C).
The incubation times were 72 hours (3 days) and 168
hours (7 days) at which time they were stored at −80 °C.
Once frozen, all aliquots were kept at −80 °C until used
for DNA extraction.
Fecal DNA extraction
Genomic DNA from stool samples was extracted with a
modification of the stool QIAamp DNA Stool mini kit
(QIAGEN, Valencia, CA). Briefly, 300 mg of feces was
mixed with 350 μL of lysis buffer composed of 0.05 M
potassium phosphate buffer containing 50 μL lyzosyme
(10 mg/mL), 6 μL of mutanolysin (25,000 U/ml; Sigma-
Aldrich) and 3 μL of lysostaphin (4,000 U/mL in sodium
acetate; Sigma-Aldrich). The mixture was incubated for
1 hour at 37 °C, then 10 μL proteinase K (20 mg/ml),
100 μL 10 % SDS, and 20 μL RNase A (20 mg/ml) were
added, and the mixture was incubated for 1h at 55 °C.
Microbial cells were lysed by mechanical disruption
(bead beating) using a FastPrep instrument (MP
Biomedicals, Solon, OH) set at 6.0 m/s for 30 sec. The
lysate was processed using the QIAsymphony SP
protocol Pathogen complex 400 (Qiagen, Gaithesburg,
MD) according to the manufacturer’s recommenda-
tion. The DNA was eluted into 100 μL of storage
buffer [QIAsymphony reagent buffer AVE (0.04 % sodiumazide), Qiagen], pH 8.0. PCR inhibitors were removed
from the extracted DNA using the Zymo-Spin IV
Spin Filter column according to the manufacturer’s
recommendations (Irvine, CA). DNA was quantified by
Quant-iT PicoGreen (Molecular Probes, Inc., Eugene, OR)
in a SpectraMax M5 microplate reader (Molecular
Devices, Sunnyvale, CA).
PCR and Illumina MiSeq sequencing of the V3-V4 regions
of 16S rRNA genes
A region of approximately 469 bp encompassing the V3
and V4 hypervariable regions of the 16S rRNA gene was
targeted for sequencing. This region provides ample
information for taxonomic classification of microbial com-
munities and was used by the Human Microbiome Project
[29]. Fusion dual barcoded primers 319F (5’ ACTCC
TACGGGAGGCAGCAG – 3’) and 806R (5’ – GGAC
TACHVGGGTWTCTAAT- 3’) were used to amplify the
V3-V4 region of bacterial 16S rRNA genes [30]. The
amplicons were pooled in equimolar concentration and
sequenced on an Illumina MiSeq Instrument using the
250 bp paired-end protocol.
Analysis of 16S rRNA (V3-V4 region) sequence data and
classification of Operational Taxonomic Units (OTUs)
Quantitative Insights Into Microbial Ecology (QIIME),
an open source software package [31] was used for
sequence analysis (see Fig. 4). Sequence reads were
filtered using the QIIME pipeline with the following
criteria to optimize the quality and integrity of the data:
i) removal of primer sequence, ii) truncation of reads
not having an average quality of 20 over a 30 bp sliding
window based on the phred algorithm [32, 33], iii) removal
of trimmed reads having less than 75 % of their original
length, and iv) removal of the paired reads that were
discarded for having less than 75 % original length. QIIME
(version 1.6.0) [31] was used for all further sequence
processing steps, including quality trimming and demulti-
plexing. Quality trimming in QIIME was performed using
the following criteria: 1) no ambiguous base calls, 2) trun-
cate sequence before 3 consecutive low quality bases and
re-evaluate for length, 3) minimum sequence length of
150 bp after trimming, and 4) remove sequences with less
than 60 % identity to a pre-built Greengenes database of
16S rRNA gene sequences (Oct, 2012 version) [34].
Further data processing included clustering similar se-
quences with less than 3 % dissimilarity using UCLUST
[35] and de novo chimera detection and removal in
UCHIME v5.1 [36]. Paired reads were stitched together
with “N” between each sequence and processed as one se-
quence in the analysis. The sequence reads were then
clustered at 97 % nucleotide sequence identity in QIIME.
A closed-reference Operational Taxonomic Unit (OTU)
picking protocol with USEARCH against the Greengenes
Fig. 4 Flow diagram for the analysis of 16S rRNA sequence data, classification of operational taxonomic units, and generation of diversity metrics
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match the Greengenes database were excluded from
further analyses. Of the 1,869,502 amplicon sequences
processed, 94.4 % (1,765,159) hit a reference sequence at
greater than or equal to 97 % sequence identity.
Microbiota metrics of alpha and beta diversity
We evaluated 14 microbiota metrics across triplicate
samples from the 10 subjects. These metrics included
relative abundances of the major phyla (Proteobacteria,
Bacteroidetes, Firmicutes, Actinobacteria), four alpha-
diversity metrics (Shannon, Chao-1, PD_WT, richness),
and beta diversity represented by PCoA scores [37].
Briefly, richness, which is the total number of unique
OTUs, does not take relative abundance of OTUs into
account. Chao1 is bias-corrected for singleton OTUs [38].
Shannon index is a conservative alpha diversity estimate
that adjusts for the relative abundance (proportion) of
each taxon. Shannon index is defined as (negative) the
sum over taxa of the product of the relative abundance of
each taxon times the natural logarithm of its relative
abundance. That is, where H is Shannon index and pi is
the proportion of total species represented by species i,
H=−Σ[(pi)*ln(pi)] [39]. PD_WT is a measure of alpha
diversity that reflects phylogenetic divergence among
OTUs within a sample. In order to compare microbiota
diversity between individuals at the same sequence depth,
a random sample of 5000 OTUs was drawn without
replacement from each sample 20 times.Weighted and unweighted UniFrac distances between
samples, which measure the pairwise phylogenetic
distances between microbial communities, were calcu-
lated in QIIME by using the existing tree from the
Greengenes database [40]. Weighted UniFrac distance
accounts for the relative abundance of each taxon in the
communities while unweighted UniFrac distance does not.
From the UniFrac distance matrix, the top three vectors
produced from a principal coordinate analysis (PCoA)
were used for downstream reproducibility analysis.
Statistical analyses
For each condition at time zero, we calculated the mean of
relative abundance or alpha diversity for each condition
across the samples from the 10 subjects. We performed
t-tests, without correcting for multiple comparisons, of
whether no media was significantly different from each of
the media conditions (RNAlater® with or without antibiotic)
for relative abundances of taxa in the four major Phyla.
Next, we used intraclass correlation coefficient (ICC)
to quantify the reproducibility of relative abundances of
taxa, alpha diversity metrics and PCoA scores based on
weighted and unweighted UniFRac distance matrix. The





between subject variability and σε
2 representing within
subject variability (at each time point). We calculated
the ICCs using the R package “ICC” estimated on a
mixed effect model [41]. For each ICC, we tested if
ICC=0, i.e. the measures are random across technical
Flores et al. Microbiome  (2015) 3:33 Page 10 of 11replicates, using permutations. A high value of ICC
(between 0 and 1) indicates a high reproducibility of
the measurement across technical replicates. We tested
whether the ICCs were different among the three media
conditions using permutations. We also quantified the
percentage of overall microbiota variability explained by
subjects by calculating a distance-based coefficient of
determination R2 estimated using an R package “vegan”
[42]. The analysis was repeated for both unweighted and
weighted UniFrac distance matrices separately for each
condition and time point.
We further investigated the reproducibility of micro-
biome measurements across time stratified by condition.
For each microbiome measurement, we first averaged
technical replicates at time 0, 3 and 7 separately for each
media condition and then calculated the ICC comparing
the technical averages at time 3 vs. 0 and 7 vs. 0. Then, we
tested whether the ICCs were similar across time and under
different media conditions. Although we had specimens
immediately frozen with no media as a control comparison,
most of this analysis was based using the appropriate media
frozen immediately after collection as the main control.
Similarly, we quantified the overall temporal stability
(comparing day 3 vs. day 0 and day 7 vs. day 0) by
calculating R2 using weighted and unweighted UniFrac
distance matrices for each condition. Although we had
specimens immediately frozen with no media as a control
comparison, most of this analysis was based using the
appropriate media frozen immediately after collection as
the main control. We tested whether the ICCs were
different among the three media conditions using permu-
tations. To test the association between ICC and relative
abundance of the many taxa, a linear regression model
was fitted to the log relative abundance of all taxa that had
minimum relative abundance of 0.1 %.
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